NASDAQ:INDV | Free Cash Flow | Indivior Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$9M$20M-$29M-32.58%
2025-12-31-$221M$24M-$245M-240.20%
2025-03-31$75M$5M$70M148.94%
2024-12-31-$17M$16M-$33M-157.14%
2024-03-31-$37M$2M-$39M-63.93%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$27M$66M-$93M-44.29%
2024-12-31$36M$29M$7M100.00%
2023-12-31-$300M$8M-$308M
2022-12-31-$4M$5M-$9M